Taken directly from the American College of Cardiology
A summary by Sarah Kohnstamm, MD, FACC
Quick Takes
- This meta-analysis set out to answer the prevalence of LA thrombus in patients with atrial fibrillation or flutter on guideline-directed anticoagulation. It further identified higher-risk populations in whom the diagnostic yield of a pre-procedure TEE would be beneficial.
- The overall prevalence of LA thrombus in patients with atrial fibrillation or flutter, receiving a minimum of 3 weeks of uninterrupted anticoagulation, was approximately 3%.
- The prevalence of LA thrombus was even higher in patients with nonparoxysmal atrial fibrillation or flutter (6.3%), CHA2DS2-VASc score ≥3 (4.81%), and those undergoing cardioversion (5.55%) as opposed to ablation.
Read the full article:
https://www.jacc.org/doi/10.1016/j.jacc.2021.04.036?_ga=2.213651092.1247377718.1624477281-193636431.1624373337
Editorial Comment:
https://www.jacc.org/doi/10.1016/j.jacc.2021.04.034
Reference:
Lurie A, Wang J, Hinnegan KJ, McIntyre WF, Belley-Côté EP, Amit G, Healey JS, Connolly SJ, Wong JA. Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation. J Am Coll Cardiol. 2021 Jun 15;77(23):2875-2886. doi: 10.1016/j.jacc.2021.04.036. PMID: 34112315.
